Tuesday - November 17, 2026
Goodwin Advises Royalty Pharma on Transactional and Intellectual Property Aspects of Royalty Stream Purchase From AstraZeneca
November 16, 2026
BOSTON, Massachusetts, Nov. 16 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Advises Royalty Pharma on Transactional and Intellectual Property Aspects of Royalty Stream Purchase From AstraZeneca

*

The Life Sciences team advised transactional and intellectual property (IP) aspects of Royalty Pharma's acquisition of a royalty in Zoryve from AstraZeneca for $100 million upfront. Zoryve, mark . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products